Status:

COMPLETED

A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

Lead Sponsor:

GlaxoSmithKline

Conditions:

Bronchospasm

Activity/Exercise Induced Bronchospasm

Eligibility:

All Genders

4-17 years

Phase:

PHASE4

Brief Summary

During this study, your child will need to attend up to 5 office visits and maintain regular telephone contact with the clinic. Certain office visits will include physical exams, medical history revie...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Diagnosed with persistent asthma for 3 months or longer.
  • Experienced worsened asthma symptoms during physical activity.
  • Using an inhaled steroid for the previous 4 weeks or longer (such as Aerobid, Azmacort, Flovent, Pulmicort, QVAR, and Vanceril).
  • Exclusion criteria:
  • Used systemic steroids as either liquids, pills, or injections to treat asthma within the previous 3 months.
  • Have only intermittent, seasonal, or exercise-induced asthma, and not persistent asthma.
  • Admitted to a hospital within the previous 6 months due to asthma symptoms.
  • Any poorly controlled medical conditions that may make study participation unsafe or inappropriate in the opinion of the study physician (such as cystic fibrosis, congenital heart disease, insulin dependent diabetes, glaucoma, drug allergies, etc.)
  • The study physician will evaluate other medical criteria.

Exclusion

    Key Trial Info

    Start Date :

    December 23 2003

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 23 2006

    Estimated Enrollment :

    248 Patients enrolled

    Trial Details

    Trial ID

    NCT00118716

    Start Date

    December 23 2003

    End Date

    April 23 2006

    Last Update

    February 5 2019

    Active Locations (50)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 13 (50 locations)

    1

    GSK Investigational Site

    Little Rock, Arkansas, United States, 72205

    2

    GSK Investigational Site

    Huntington Beach, California, United States, 92647

    3

    GSK Investigational Site

    Orange, California, United States, 92868

    4

    GSK Investigational Site

    Palmdale, California, United States, 93551